Employees: 01 (2023.0)Legal category: SCA (commandite par actions)Size: PMECreation date: 2005-03-14 (21 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LA MOTTE-D'AVEILLANS (38770), Isere
PHARMACIE DE LA PIERRE PERCEE : revenue, balance sheet and financial ratios
PHARMACIE DE LA PIERRE PERCEE is a French company
founded 21 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LA MOTTE-D'AVEILLANS (38770),
this company of category PME
shows in 2019 a revenue of 463 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA PIERRE PERCEE (SIREN 481385946)
Indicator
2023
2019
2018
2017
2016
Revenue
N/C
462 836 €
535 999 €
667 853 €
735 903 €
Net income
56 213 €
3 592 €
-17 811 €
-24 587 €
36 300 €
EBITDA
N/C
15 381 €
295 €
4 885 €
70 903 €
Net margin
N/C
0.8%
-3.3%
-3.7%
4.9%
Revenue and income statement
In 2023, PHARMACIE DE LA PIERRE PERCEE generates positive net income of 56 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 36 k€ -> 56 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
56 213 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 82%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 30%. The balance between equity and debt is satisfactory.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
82.201%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
30.424%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA PIERRE PERCEE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2023
Debt ratio
183.865
194.144
229.285
243.868
82.201
Financial autonomy
21.293
18.682
15.898
14.486
30.424
Repayment capacity
5.938
-10.898
-11.759
72.464
None
Cash flow / Revenue
5.568%
-2.874%
-3.272%
0.615%
None%
Sector positioning
Debt ratio
82.22023
2018
2019
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average-15 pts over 3 years
In 2023, the debt ratio of PHARMACIE DE LA PIERRE PE... (82.20) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
30.42%2023
2018
2019
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average
In 2023, the financial autonomy of PHARMACIE DE LA PIERRE PE... (30.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
72.46 years2019
2018
2019
Q1: 1.73 years
Med: 5.0 years
Q3: 9.48 years
Watch+51 pts over 2 years
In 2019, the repayment capacity of PHARMACIE DE LA PIERRE PE... (72.46) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 143.78. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
143.783
Liquidity indicators evolution PHARMACIE DE LA PIERRE PERCEE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2023
Liquidity ratio
125.967
103.956
97.89
96.166
143.783
Interest coverage
31.701
361.494
-878.983
6.352
None
Sector positioning
Liquidity ratio
143.782023
2018
2019
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Average+8 pts over 3 years
In 2023, the liquidity ratio of PHARMACIE DE LA PIERRE PE... (143.78) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
6.35x2019
2018
2019
Q1: 1.36x
Med: 5.41x
Q3: 11.35x
Good+32 pts over 2 years
In 2019, the interest coverage of PHARMACIE DE LA PIERRE PE... (6.3x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA PIERRE PERCEE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2023
Operating WCR
211 565 €
123 793 €
120 744 €
137 569 €
0 €
Inventory turnover (days)
63
52
57
58
0
Customer payment term (days)
22
18
25
26
0
Supplier payment term (days)
136
149
190
249
0
Positioning of PHARMACIE DE LA PIERRE PERCEE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE DE LA PIERRE PERCEE is estimated at
663 283 €
(range 403 374€ - 932 428€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
403k€663k€932k€
663 283 €Range: 403 374€ - 932 428€
NAF 5 année 2023
Valuation method used
Net Income Multiple
56 213 €
×
11.8x
=663 284 €
Range: 403 375€ - 932 428€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA PIERRE PERCEE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA PIERRE PERCEE
What is the revenue of PHARMACIE DE LA PIERRE PERCEE ?
The revenue of PHARMACIE DE LA PIERRE PERCEE in 2019 is 463 k€.
Is PHARMACIE DE LA PIERRE PERCEE profitable?
Yes, PHARMACIE DE LA PIERRE PERCEE generated a net profit of 56 k€ in 2023.
Where is the headquarters of PHARMACIE DE LA PIERRE PERCEE ?
The headquarters of PHARMACIE DE LA PIERRE PERCEE is located in LA MOTTE-D'AVEILLANS (38770), in the department Isere.
Where to find the tax return of PHARMACIE DE LA PIERRE PERCEE ?
The tax return of PHARMACIE DE LA PIERRE PERCEE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA PIERRE PERCEE operate?
PHARMACIE DE LA PIERRE PERCEE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart